You are here

  • Home
  • Archive
  • Volume 75, Issue 11
  • Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

Citation Tools

Article menu
Clinical and epidemiological research
Extended report
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kaneko Y, Atsumi T, Tanaka Y, et al
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)
Annals of the Rheumatic Diseases 2016;75:1917-1923.